The OS analysis indicated that DTYMK was a potential independent prognostic biomarker for patients with ACC, DLBC, LGG, LIHC, LUAD, MESO, SKCM, and UVM (Figure 8A). The gene discussed is DTYMK; the disease is adrenal cortex carcinoma.